Literature DB >> 14734752

IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA.

William J Kaiser1, Jonathan L Kaufman, Margaret K Offermann.   

Abstract

The ability of endothelial cells to mount an efficient antiviral response is important in restricting viral dissemination and eliminating viral infection from the endothelium and surrounding tissues. We demonstrate that dsRNA, a molecular signature of viral infection, induced apoptosis in HUVEC, and priming with IFN-alpha shortened the time between when dsRNA was encountered and when apoptosis was initiated. IFN-alpha priming induced higher levels of mRNA for dsRNA-activated protein kinase, 2'5'-oligoadenylate synthetase, and Toll-like receptor 3, transcripts that encode dsRNA-responsive proteins. dsRNA induced activation of dsRNA-activated protein kinase and nuclear translocation of transcription factors RelA and IFN regulatory factor-3 in IFN-alpha-primed HUVECs before the activation of intrinsic and extrinsic apoptotic pathways. These changes did not occur in the absence of dsRNA, and apoptosis resulting from incubation with dsRNA occurred much later when cells were not primed with IFN-alpha. The entire population of IFN-alpha-primed HUVECs underwent nuclear translocation of RelA and IFN regulatory factor-3 in response to dsRNA, whereas less than one-half of the population responded with apoptosis. When IFN-alpha-primed HUVECs were coincubated with dsRNA and proteasome inhibitors, all HUVECs were rendered susceptible to dsRNA-induced apoptosis. These studies provide evidence that many endothelial cells that are alerted to the risk of infection by IFN-alpha would undergo apoptosis sooner in response to dsRNA than non-IFN-alpha-primed cells, and this would enhance the likelihood of eliminating infected cells prior to the production of progeny virions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734752     DOI: 10.4049/jimmunol.172.3.1699

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.

Authors:  Joy Jones Buie; Ludivine L Renaud; Robin Muise-Helmericks; Jim C Oates
Journal:  J Immunol       Date:  2017-08-04       Impact factor: 5.422

2.  Symptomatic interferon retinopathy successfully treated by hypertension management.

Authors:  C Han; J O'Day
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

3.  Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).

Authors:  Ruili Sun; Yu Zhang; Qingshan Lv; Bei Liu; Miao Jin; Weijia Zhang; Qing He; Minjie Deng; Xueting Liu; Guancheng Li; Yuehui Li; Guohua Zhou; Pingli Xie; Xiumei Xie; Jinyue Hu; Zhaojun Duan
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

4.  Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.

Authors:  Olivier A Harari; Pilar Alcaide; Daniela Ahl; F William Luscinskas; James K Liao
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

5.  Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers.

Authors:  Minoru Nakamura; Kenji Funami; Atsumasa Komori; Terufumi Yokoyama; Yoshihiro Aiba; Aiko Araki; Yasushi Takii; Masahiro Ito; Mutsumi Matsuyama; Makiko Koyabu; Kiyoshi Migita; Ken Taniguchi; Hikaru Fujioka; Hiroshi Yatsuhashi; Misako Matsumoto; Hiromi Ishibashi; Tsukasa Seya
Journal:  Hepatol Int       Date:  2008-03-26       Impact factor: 6.047

6.  Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.

Authors:  Seth G Thacker; Wenpu Zhao; Carolyne K Smith; Wei Luo; Hui Wang; Anuradha Vivekanandan-Giri; Bradley J Rabquer; Alisa E Koch; Subramaniam Pennathur; Anne Davidson; Daniel T Eitzman; Mariana J Kaplan
Journal:  Arthritis Rheum       Date:  2012-09

7.  Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro.

Authors:  Asuman Deveci Ozkan; Gamze Guney Eskiler; Suleyman Kaleli; Elvan Sahin
Journal:  Mol Biol Rep       Date:  2021-11-26       Impact factor: 2.316

8.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi's sarcoma cell line.

Authors:  April J Livengood; Christina C N Wu; Dennis A Carson
Journal:  Cell Immunol       Date:  2007-12-26       Impact factor: 4.868

10.  The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.

Authors:  John A Reynolds; David W Ray; Leo A H Zeef; Terence O'Neill; Ian N Bruce; M Yvonne Alexander
Journal:  J Interferon Cytokine Res       Date:  2014-01-20       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.